More What is the Optimal Temperature for Sanitizing Water Systems?
More FDA Warning Letter: Deficiencies in API / Finished Drug Product Testing and Stability Program
More Numerous FDA 483s due to Deficiencies in the Stability Program
More Lack of Scientifically Sound Laboratory Controls often mentioned in FDA 483s Reports
More Inadequate Sampling Plans lead to FDA 483 Inspection Report
More Aide-Memoire from the PIC/S regarding the Inspection of Quality Risk Management
More New Updates of the Templates for Reporting Nitrosamine Contamination
More Analytical Procedure Life Cycle - New USP Chapter <1220> published
More New FDA Draft Guidance - Microbiological Quality Control of Non-Sterile Medicinal Products
More FDA Warning Letter Due to Lack of Stability Data and Specifications for APIs
More FDA´s Q&As on Generic Drug Development during the COVID-19 Pandemic